The acquisition of SomaLogic by Illumina is expanding Illumina's capabilities into proteomics and precision medicine.

5 reports, 0 independent Updated Jul 4

Gone quiet

Reports: 5
Developments: 2
Repetition: 60%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

The acquisition of SomaLogic by Illumina is expanding Illumina's capabilities into proteomics and precision medicine.

Who's involved

What this event is mainly about

Illumina SomaLogic

How it developed

Newest first. Tap a step to see who reported it.

Jul 4The acquisition is expanding Illumina's capabilities into proteomics and precision medicine.
Jun 24Illumina seeks to strengthen its proteomics capabilities.

Keep exploring

Part of

Illumina announced an agreement to acquire SomaLogic on September 3, 2025, utilizing SomaLogic's technology for new assays. All 2 developments

The entities involved

Illumina
American company that develops systems for the analysis of genetic variation
- Analysis suggests that both Moderna and Illumina stocks are currently overvalued.Wed 13:01
SomaLogic
company in Boulder, United States

Nothing else this week.

Related events

Illumina and MindWalk Holdings Corp. have partnered, with both companies operating in the field of AI-enabled drug discovery.Sep 3

Coverage

Newest first; wire copies grouped

Jul 4Unknown outlet
Jun 26Unknown outlet
Jun 25Unknown outlet
Jun 24Unknown outlet
Jun 23Unknown outlet